Skip to main content

Find Clinical Trials

Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,392 public trials 2,847 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

NCT05924750

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Anhui Provincial Hospital Hefei, Anhui, China

Beijing Hospital Beijing, Beijing Municipality, China

Institute of Hematology, the First Hospital of Harbin Haerbin, Heilongjiang, China

Shengjing Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Recruiting

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

NCT06398457

Conditions: Acute Lymphoblastic Leukemia (ALL), Adult, Acute Myeloid Leukemia (AML), Anemia, +45 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Recruiting

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

NCT06358638

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: Children's National Hospital Washington D.C., District of Columbia, United States

View Trial Details

Recruiting

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities

NCT04314752

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Recruiting

Clinical Trial Using CAR- T Cells for Treatment of Patients With Refractory or Relapsed CD19-positive B Lymphoid Malignancies

NCT05705570

Conditions: Acute Lymphoblastic Leukemia Refractory, Acute Lymphoblastic Leukemia, in Relapse, B-cell Lymphoma Recurrent, +14 more
Locations: Hospital Israelita Albert Einstein São Paulo, Brazil

View Trial Details

Recruiting

CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma

NCT05722418

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

CU Anschutz Medical Campus, Anshutz Cancer Pavillion Aurora, Colorado, United States

Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics Miami, Florida, United States

University of Kentucky/ Markey Cancer Center Lexington, Kentucky, United States

View all 16 locations

View Trial Details

Recruiting

Precision Medicine Study

NCT06338150

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Mount Sinai Health System New York, United States

View Trial Details

Recruiting

I Can Move With Purpose Now! A Pilot Lifestyle Intervention Study in Myeloproliferative Neoplasm Patients

NCT05842603

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

View Trial Details

Recruiting

Comparison of the Effects of Apixaban on Thrombin Generation in Patients With de Novo Multiple Myeloma

NCT06474182

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: CHU de Saint-Etienne Saint-Etienne, France

View Trial Details

Recruiting

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

NCT06501196

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: City of Hope Medical Center Duarte, California, United States

University of California Los Angeles Los Angeles, California, United States

Stanford Cancer Center Palo Alto, California, United States

Sylvester Comprehensive Cancer Center Miami, Florida, United States

View all 13 locations

View Trial Details